VV Venture Valuation

What VV Venture Valuation does

Venture Valuation (legal entity Venture Valuation VV AG) is a privately held Swiss professional services firm founded in 1999 by Dr. Patrik Frei, headquartered in Zurich with additional offices in Ireland, the United Kingdom, Canada, the United States, and Asia. The firm provides independent third-party valuation services for life science companies, with a specialization in biotechnology, pharmaceuticals, and medical technology. Offerings include company valuations for financing rounds and M&A, product and IP asset valuations supporting licensing negotiations, investor services such as portfolio monitoring, net asset value calculation, fairness opinions, and arbitrations, as well as partner search and workshop/training services.

The firm operates a parallel platform business through its wholly owned subsidiaries Biotechgate, HelloPartnering, and Biotechgate Digital Partnering. Biotechgate is a global business development and licensing database covering over 65,000 life science company profiles, 40,000+ licensing deals, and more than 1 million clinical trial records. The platform was augmented in June 2026 with an AI Workspace providing semantic search and natural language querying capabilities. HelloPartnering and Biotechgate Digital Partnering provide conference and matchmaking tools for onsite, virtual, and hybrid partnering events.

Revenue is generated through two complementary mechanics: project-based professional services fees for valuation engagements (priced per engagement with multi-year contracts), and recurring subscription revenue from access to the Biotechgate database and related regional directories. Distribution relies on enterprise field sales, conference presence (BIO International, JPM Week, RESI, BioTrinity), and content marketing through whitepapers, industry reports, and a published interview series. The firm was founded on research from the University of St. Gallen (HSG) and EPFL, and its team combines scientific and finance expertise; its authored body of work includes publications in Nature Biotechnology and two books on valuation methodology.

Name

VV Venture Valuation

Legal name

Venture Valuation VV AG

Website

https://venturevaluation.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

Venture Valuation provides independent third-party valuation services and the Biotechgate BD&L database for life science companies and their investors, specializing in biotechnology, pharmaceuticals, and medical technology companies globally.

Ownership category

akta.pro rank

Headquarters

HQ city

Zürich

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Company and Product Valuation Services: Independent third-party valuation reports for life science companies and products/assets, serving entrepreneurs (seed to pre-IPO) and investors. Services include fairness opinions and arbitrations for investors.
2. Biotechgate Database Subscription: Subscription-based access to the Biotechgate business development and licensing database covering over 65,000 life science company profiles, licensing deals, and clinical trials data.
3. Partner Search Services: Helps Pharma and Biotech companies find targeted in-licensing opportunities using global network and Biotechgate database.
4. Workshop and Training Services: Interactive workshops on valuation and financing provided in virtual, face-to-face and in-house formats.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

VV Venture Valuation provides independent third-party valuation services for life sciences companies, including company valuation, product and asset valuation, fairness opinions, and partner/in-licensing search. The firm also operates Biotechgate, a global business development and licensing database covering over 65,000 life science company profiles, licensing deals, and clinical trials data, along with partnering platforms and workshops.

Product overview

VV Venture Valuation operates two core product families: (1) Venture Valuation professional valuation services including Company Valuation, Product Valuation, Services for Investors, Partner Search, and Workshops; and (2) Biotechgate platform comprising the BD&L Database (65,000+ company profiles, 40,000+ licensing deals, 1M+ clinical trial records), Biotechgate Digital Partnering events platform, HelloPartnering conference/matchmaking platform, Regional Directories (30+), and the AI Workspace feature for semantic search. The company provides independent third-party assessment and valuation for life science companies specializing in biotech, pharma, and medtech sectors.

Differentiator

Problem solved

Functional benefit

Brands

• Biotechgate: Leading business development and licensing platform for the life science industry offering company profiles, financing rounds, licensing deals, and clinical trials database
• HelloPartnering
• Biotechgate Digital Partnering

Products and services

• Company Valuation Independent third-party valuation of biotech, pharma and medtech companies, tailored to financing rounds, M&A transactions, and strategic decision-making for entrepreneurs and investors.
• Product Valuation Independent valuation of products, IP assets and licensing deal structures, helping clients understand the financial impact and risk/return profile of projects and in-licensing opportunities.
• Services for Investors Investor support services including portfolio company monitoring, net asset value calculation, fairness opinions, and arbitration services for venture capital, corporate venture, and asset management clients.
• Partner Search Targeted in-licensing opportunity identification and partner search for pharma and biotech companies using the global Biotechgate network and database.
• Biotechgate BD&L Database Subscription-based global business development and licensing database covering over 65,000 life science company profiles including assets, clinical trials, financing rounds, licensing activities, and key management details.
• Biotechgate Digital Partnering Digital partnering event platform designed to support business development and licensing activities for pharma, biotech, medtech and digital health companies through conferences, workshops, networking and one-to-one meetings.
• HelloPartnering Conference and matchmaking platform supporting onsite, virtual or hybrid partnering conferences for business development activities in the life sciences industry.
• Workshops

Named customers13 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

13 partnerships are on record, tiered core and minor.

• BioFloridacoreStrategic or Co-development Partner · 1 November 2024Strategic partnership with BioFlorida to enhance USA Life Sciences Database, expanding coverage of Florida's life science ecosystem.
• One NucleuscoreStrategic or Co-development Partner · 1 September 2023Partnership to boost life sciences connectivity and innovation, enhancing the Cambridge/London biotech ecosystem integration with Biotechgate.
• AdvaMed (Advanced Medical Technology Association)coreStrategic or Co-development Partner · 1 August 2023Partnership to drive MedTech industry growth by integrating AdvaMed member data into the Biotechgate database.
• ALLIS-NA (Alliance Innovation Santé Nouvelle-Aquitaine)coreStrategic or Co-development Partner · 1 March 2023Partnership to accelerate data integration in Biotechgate and economic development of life science industry in Nouvelle-Aquitaine region of France. Created comprehensive membership directory for ALLIS-NA featuring over 140 members.
• Enterprise LithuaniacoreStrategic or Co-development Partner · 1 January 2021Partnership to enhance visibility of Lithuanian life science companies through Biotechgate database and directory.
• KPMGcoreStrategic or Co-development Partner · 1 July 2020Collaboration on site selection report for life sciences companies in Asia, providing market intelligence and advisory services.
• BioRNcoreStrategic or Co-development Partner · 1 March 2020Partnership with BioRN, the science and industry cluster of the Rhine-Main-Neckar region, to develop and run a publicly accessible directory of life science companies in the region. Fifth partner of Biotechgate/Venture Valuation in Germany.
• Ferring PharmaceuticalscoreStrategic or Co-development Partner · 1 March 2019Working with Ferring Pharmaceutical to support with external, third-party product/asset valuations of potential in-licensing opportunities in women's health.
• Maryland Biotechnology CentercoreStrategic or Co-development Partner · 1 April 2009Partnership to enhance Biotechgate and USA Life Sciences Database with Maryland biotechnology companies.
• KAPPA-HealthminorStrategic or Co-development Partner · 1 March 2009EU-funded project to help SMEs benefit from their participation in EU funded R&D projects.
• Swissnex SingaporeminorStrategic or Co-development Partner · 1 June 2008Partnership for biotech industry and valuation presentations in Singapore through Swissnex network.
• NaturejobsminorStrategic or Co-development Partner · 1 December 2007Collaboration to aid recruiters and job seekers globally in the biotech sector.
• BIOTECanadacoreStrategic or Co-development Partner · 1 April 2007Launch of online database of Canadian life sciences companies through partnership with BIOTECanada.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Houlihan Lokey: Global investment bank with a strong valuation and financial opinions practice serving pharma and biotech clients. A broader incumbent that overlaps on life sciences valuation mandates.
• Deloitte: Big Four firm with dedicated life sciences valuation and advisory practice. Competes for high-end valuation, fairness opinions, and transaction advisory mandates.
• IQVIA: Largest healthcare data and analytics provider with deep life sciences coverage including clinical, commercial, and real-world data. A much broader incumbent in life sciences intelligence and advisory.
• PwC: Big Four firm with global valuation practice serving life sciences clients on financial reporting valuations and transactions. Competes on larger enterprise mandates.
• Charles River Associates: Consulting firm with a life sciences practice providing commercial assessments and economic valuation for pharma and biotech transactions. Overlaps on complex life sciences valuation work.

Direct peers

• Evaluate (formerly EvaluatePharma): Provides pharma industry data, forecasts, and deal analytics to life sciences companies and investors. Comparable to Biotechgate for company, asset, and deal-level intelligence used in valuation work.
• Kroll (formerly Duff & Phelps): Global valuation and advisory firm with established life sciences valuation practice providing fairness opinions and complex asset valuations. Direct competitor for life sciences valuation mandates.
• BioCentury: Long-standing life sciences business intelligence provider focused on BD&L, licensing, and strategic analysis for biotech and pharma. Overlaps with Venture Valuation's BD&L intelligence and licensing deal coverage.
• Informa Pharma Intelligence (Citeline): Provides pharma and biotech intelligence databases (trials, deals, company profiles) overlapping with Biotechgate's BD&L platform. Both serve life sciences business development teams with subscription data products.
• Valuation Research Corporation: Independent, pure-play valuation firm serving financial reporting, tax, and corporate purposes. Competes for life sciences valuation engagements and corporate finance advisory work.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/venture-valuation-ag

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VV Venture Valuation